We are monitoring the impact of COVID-19 on Europe Insulin Pump Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11303
Share on
Share on

Europe Insulin Pump Market Research Report – Segmented By Type, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: March, 2021
ID: 11303
Pages: 100

Europe Insulin Pump Market Size (2021 to 2026)

As per our report, the European insulin pump market size is forecasted to worth USD 3.12 Billion by 2026, registering a CAGR of 6.4% from 2021 to 2026.

Y-O-Y growth in the prevalence of diabetes in various age groups in the European region is due to obesity, unhealthy diet and physical inactivity is one of the primary factors driving the European insulin pump market growth. The prevalence of autoimmune type 1 diabetes is also increasing in Europe, and, according to sources, Europe has the highest number of children with type 1 diabetes patients. The other significant factors contributing to the growth of the European insulin pump market are the increasing aging population, growing prevalence of diabetes, awareness of the benefits of an insulin pump, increasing disposable income per capita, and progressive diabetes infrastructure.

The gradual advancement of insulin pumps and their rapid adoption by diabetic patients over conventional techniques opens up strong opportunities for the insulin pump market in Europe.

The healthcare industry is growing rapidly in the European region, particularly the healthcare provider is well aligned, and the institutional diabetes network is sufficiently dispersed to capture all demographics. Thus, the service is accessible to all diabetes training for certified health professionals (HCP), assistants, and new patients. In addition, there are a large number of insulin pump manufacturers in Europe that, from time to time, launch new products with great advancements and features.

High costs associated with the insulin pumps, inadequate reimbursement policies, and the availability of other substitutes may hamper the growth rate of the insulin pump market in Europe.

Impact of COVID-19 on the European Insulin Pump Market:

The impact of COVID-19 on the insulin pump market has been such that the increase in the number of diabetic patients leads to high use of insulin pumps, leading to increased sales in the insulin pump market. Diabetic patients search for essential health products in several ways, such as hospital pharmacies, online portals, and emergency drug stores. The COVID-19 pandemic has had a huge impact on the medical device industry, mainly with the increase in demand for protective equipment such as respiratory pumps, insulin devices, and mouth cover, which has once again fueled the market snowball.

There have even been numerous government actions to manage the pandemic by manufacturing insulin pump supply chains, as diabetic patients are at increased risk of being affected by COVID-109. Therefore, with constant access to essential drugs, technologies, and treatments, smart insulin manufacturing companies are taking various steps to make the product available to patients, which has been well suited to the market valuation.

This research report on the European insulin pump market has been segmented and sub-segmented into the following categories:

By Pump Type:

  • Traditional
  • Disposable

By End User:

  • Hospitals & Clinics
  • Homecare
  • Laboratories
  • Others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European insulin pumps market is predicted to account for a significant share in the global market during the forecast period.

In Europe, Germany is one of the largest markets for insulin pumps due to its large number of diabetic patients, type 1 diabetes patients, and improved reimbursement policies. Germany held a 34% market share of the European insulin infusion pump market in 2019 and is expected to register a CAGR of 4.2% during the forecast period due to favorable reimbursement policies.

The UK has many reimbursement policies which contribute to a promising growth rate for the UK insulin pump market during the forecast period.

The France insulin pump market is expected to showcase a prominent CAGR due to advanced health infrastructure during the forecast period.

Due to the increasing number of diabetic patients and the growing awareness of blood sugar control and advanced insulin delivery devices in these regions like Sweden, the Netherlands, Norway, etc., notable growth in the insulin pump market is expected.

KEY MARKET PLAYERS:

Animus Corporation, Asante, Cellnovo Ltd., Insulet Corporation, Medtronics, Inc., Nipro Diagnostic, Inc., Ypsomed, Roche, Sooil Development Co., Ltd., and Tandem Diabetes Care, Inc. are some of the noteworthy companies in the European insulin pump market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Traditional Insulin Pumps
      2. Disposable Insulin Pumps
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By End User
      1. Hospitals & Clinics
      2. Homecare
      3. Laboratories
      4. Others
      5. Y-o-Y Growth Analysis, By End User
      6. Market Attractiveness Analysis, By End User
      7. Market Share Analysis, By End User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends       
      2. Impact Analysis        
      3. Y-o-Y Growth Analysis            
        1. By Geographical Area
        2. By Type
        3. By End User
      4. Market Attractiveness Analysis          
        1. By Geographical Area
        2. By Type
        3. By End User
      5.          Market Share Analysis   
        1. By Geographical Area
        2. By Type
        3. By End User
    2. Asia-Pacific
      1. Introduction
      2. United Kingdom
      3. Germany
      4. France
      5. Spain
      6. Italy
      7. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Animus Corporation (U.S.)
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Asante (U.S.)
    3. Cellnovo Ltd. (U.K.)
    4. Insulet Corporation (U.S.)
    5. Medtronics, Inc. (U.S.)
    6. Nipro Diagnostic, Inc. (Japan)
    7. Ypsomed (Switzerland)
    8. Roche (Switzerland)
    9. Sooil Development Co., Ltd. (Korea)
    10. Tandem Diabetes Care, Inc. (U.S.)
  9. Competitive Landscape
    1. Merger and Acquisition Analysis
    2. Agreements, Collaborations and Joint Ventures
    3. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of pump type and end-user, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  2. Europe Traditional Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Disposable Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)
  5. Europe Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe HomeCare Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  9. U.K. Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  10. U.K. Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)
  11. Germany Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  12. Germany Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)
  13. France Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  14. France Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)
  15. Italy Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  16. Italy Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)
  17. Spain Insulin Pump Market, By Pump Type, From 2021 to 2026 (USD Million)
  18. Spain Insulin Pump Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample